Unbound MEDLINE

Concomitant use of pazopanib and simvastatin increases the risk of transaminase elevations in patients with cancer.

Links

  • Publisher Full Text

    • Authors

    Xu CF, Xue Z, Bing N, King KS, McCann LA, de Souza PL, Goodman VL, Spraggs CF, Mooser VE, Pandite LN

    Source

    Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 23:9 2012 Sep pg 2470-1

    MeSH

    ATP-Binding Cassette Transporters
    Alanine Transaminase
    Anticholesteremic Agents
    Antineoplastic Agents
    Clinical Trials as Topic
    Drug Interactions
    Drug-Induced Liver Injury
    Humans
    Hypercholesterolemia
    Incidence
    Neoplasm Proteins
    Neoplasms
    Polymorphism, Single Nucleotide
    Pyrimidines
    Reference Values
    Simvastatin
    Sulfonamides

    Pub Type(s)

    Letter
    Research Support, Non-U.S. Gov't

    Language

    eng

    PubMed ID

    22918879